LoginSignup
Fresenius logo

Fresenius

Stock
Stock
ISIN: DE0005785604
Ticker: FRE
DE0005785604
FRE

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 23.05.2025

$0.404

CHART BY

Frequently asked questions

What is Fresenius's market capitalization?

The market capitalization of Fresenius is $19.50B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Fresenius?

Fresenius's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.709. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Fresenius's stock?

Currently, 17 analysts cover Fresenius's stock, with a consensus target price of $41.57. Analyst ratings provide insights into the stock's expected performance.

What is Fresenius's revenue over the trailing twelve months?

Over the trailing twelve months, Fresenius reported a revenue of $23.16B.

What is the EBITDA for Fresenius?

Fresenius's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.12B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Fresenius?

Fresenius has a free cash flow of $2.35B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Fresenius have, and what sector and industry does it belong to?

Fresenius employs approximately 193,865 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Fresenius's shares?

The free float of Fresenius is 411.09M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$19.50B
EPS (TTM) 
-$0.709
Free Float 
411.09M
Revenue (TTM) 
$23.16B
EBITDA (TTM) 
$3.12B
Free Cashflow (TTM) 
$2.35B

Pricing

1D span
$34.02$34.97
52W span
$26.28$39.59

Analyst Ratings

The price target is $41.57 and the stock is covered by 17 analysts.

Buy

15

Hold

2

Sell

0

Information

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Employees
193,865
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DE0005785604
Primary Ticker
FRE

Knockouts

Join the conversation
Sign upLogin